PRESS RELEASE
News
-
-
PRESS RELEASE
Form 8.3 - The Vanguard Group, Inc.: LXi REIT plc
The Vanguard Group, Inc. has made a public opening position disclosure and dealing disclosure for LXi REIT plc. The disclosure includes their interests and short positions in the relevant securities, along with details of any dealings made. No indemnity or other dealing arrangements are reported. -
PRESS RELEASE
Form 8.3 - The Vanguard Group, Inc.: Molten Ventures plc
The Vanguard Group, Inc. has made a public opening position disclosure, revealing their interests in Molten Ventures plc and relevant securities. The disclosure includes details of their ownership, short positions, and dealings in 1p ordinary class securities. The disclosure also covers any potential subscriptions for new securities and other relevant information. -
PRESS RELEASE
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc
The Vanguard Group, Inc. has made a public opening position disclosure and dealing disclosure for Network International Holdings plc. The disclosure includes interests and short positions in the relevant securities, as well as details of any dealings by the disclosing person. No indemnity or other dealing arrangements and no agreements, arrangements, or understandings relating to options or derivatives are reported in this disclosure. -
PRESS RELEASE
Zentek Announces Eric Wallman Appointed as Chairman of the Board
Zentek Ltd., an intellectual property development and commercialization company, announces the resignation of Dr. Francis Dubé as Chairman of the Board and the appointment of Mr. Eric Wallman as the new Chairman according to best practices in governance. The company continues to focus on research, development, and commercialization of novel products, including their patented technology platform, ZenGUARD™, known for its anti-microbial activity and increased filtration efficiency. -
PRESS RELEASE
United Health Products Reports on FDA Application Status
United Health Products (UEEC) reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze as part of its FDA application process. The reported data on the efficacy of the proposed radiation sterilization protocol were well within acceptable bioburden levels for Class III products, and the company will proceed with final drafting of the PMA documentation for submission. The press release raises awareness about the company's ongoing FDA application status and its pursuit of approval for its hemostatic products. -
PRESS RELEASE
Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
The Vanguard Group, Inc. has disclosed a 5.21% interest in LondonMetric Property plc, owning 57,000,877 10p ordinary shares. The disclosure also indicates the purchase of 5,770 10p ordinary shares at a price of 1.83 GBP per unit. The disclosure, made on 19th January 2024, provides detailed information about the positions and dealings by the person making the disclosure. -
-
REGULATED PRESS RELEASE
Thales - Half-year liquidity contract statement on 31 December 2023
Thales has released its half-year liquidity contract statement, showing the resources in the liquidity account on December 31st, 2023, as per the terms of its liquidity contract with Kepler Cheuvreux, in accordance with AMF Decision N° 2021-01. -
PRESS RELEASE
EQS-Adhoc: Blue Cap AG: Blue Cap AG exceeds its earnings forecast for the 2023 financial year according to initial calculations
Blue Cap AG has exceeded its earnings forecast for the 2023 financial year based on initial calculations, with an expected adjusted EBITDA margin of 8.3-8.5% for continuing operations. This positive development is attributed to better than expected operational business performance and successful negotiations for compensation payments. The company is set to present its preliminary business figures for 2023 and an outlook for the 2024 financial year in the first half of March.
